neurostimulation

The US Food and Drug Administration (FDA) has approved Abbott Laboratories' Proclaim XR neurostimulation system for chronic pain patients. The device has a battery life of up to 10 years, the company announced. The Proclaim XR platform uses the company's proprietary low energy BurstDR...